Cancer immunotherapy has revolutionized treatment paradigms by harnessing the immune system to combat cancer. This session will delve into recent innovations such as CAR-T cell therapy, immune checkpoint inhibitors, and cytokine therapies. Speakers will discuss mechanisms of action, patient selection criteria, and clinical trial outcomes. The session aims to provide insights into improving response rates, managing immune-related adverse events, and expanding the applicability of immunotherapy across different cancer types.